The Incredible Benefits of Vitamin D3 and K2-MK7 for Your Health
|
|
Time to read 6 min
|
|
Time to read 6 min
Vitamin D3 and vitamin K2-MK7 are among the most studied micronutrients in nutritional medicine and sports medicine. Individually, each plays a major physiological role; together, they form a documented synergy for bone and cardiovascular health. Yet vitamin D deficiency affects a significant proportion of the European population depending on the season, and vitamin K2 remains largely under-consumed in modern Western diets.
This guide details the mechanisms of action, clinically documented benefits, commonly studied dosages, and practical uses of the D3 + K2-MK7 combination for athletes and the general population concerned with their long-term health.
Vitamin D3 (cholecalciferol) is a fat-soluble vitamin synthesized in the skin under the action of solar UVB rays and provided in small amounts by food (oily fish, eggs, liver). It is activated in two stages â in the liver into 25(OH)Dâ, then in the kidneys into calcitriol (1,25(OH)âDâ), its biologically active form. Vitamin K2-MK7 (menaquinone-7) is one of the most studied forms of vitamin K2, with a long half-life compared with K1 and MK-4, potentially allowing prolonged action on vitamin K-dependent proteins.
Vitamin D3 promotes intestinal calcium absorption and renal phosphorus reabsorption, two elements essential for bone mineralization. K2-MK7 helps activate osteocalcin and matrix Gla protein (MGP), two vitamin K-dependent proteins involved in binding calcium within the bone matrix and limiting its precipitation in soft tissues and arterial walls. This complementarity is the biochemical foundation of D3-K2 synergy.
MGP (Matrix Gla Protein) is one of the natural inhibitors of vascular calcification. Without sufficient K2, MGP remains inactive (uncarboxylated) and performs its protective role less effectively. Geleijnse et al. showed, in the prospective Rotterdam cohort (4,807 participants followed for up to 10 years), that high dietary intake of menaquinone (vitamin K2) was associated with a significantly reduced risk of coronary mortality and severe aortic calcification, whereas phylloquinone (vitamin K1) intake was not associated with either outcome (Journal of Nutrition, DOI).
Active vitamin D3 is involved in the regulation of numerous genes involved in innate and adaptive immunity. It stimulates the production of antimicrobial peptides (defensins, cathelicidin) and is being studied for its potential role in modulating inflammatory responses, with particular interest for deficient individuals during winter.
Vitamin D receptors (VDR) are present in skeletal muscle cells. Adequate vitamin D status is associated in several observational studies with better muscle strength and a potentially reduced risk of injury in certain profiles, particularly when correcting a confirmed deficiency â the extent of the benefit in athletes already well supplied with vitamin D remains more uncertain.
D3 regulates calcium absorption and use; K2-MK7 helps direct its distribution â toward bones rather than arteries. Both act on distinct yet complementary proteins for bone and cardiovascular health. Together, they provide consistent micronutritional coverage, although clinical trials directly combining both molecules remain relatively limited compared with studies on each vitamin separately.
Practices vary according to initial status (serum testing is recommended before high-dose supplementation):
| Criterion | D3 alone | D3 + K2-MK7 | D2 (ergocalciferol) |
|---|---|---|---|
| Bioavailability | High | High | Generally lower than D3 |
| 25(OH)Dâ increase | Effective | Effective | Generally less effective |
| Cardiovascular support | Partial | Potentially optimized (active MGP) | Not documented |
| K2 duration of action | â | Longer (MK-7 vs MK-4) | â |
| Recommendation | Acceptable | Consistent combination | Vegan option |
Knapen et al. showed, in a randomized controlled trial involving 244 postmenopausal women followed for 3 years, that K2-MK7 supplementation (180 ”g/day) significantly slowed the age-related decline in bone mineral density at the lumbar spine and femoral neck (but not the total hip), and improved certain bone strength indices (Osteoporosis International, DOI). Braam et al. specifically studied vitamin K1 (rather than K2-MK7) alongside minerals and vitamin D in 181 postmenopausal women over 3 years, observing a modest reduction in bone loss at the femoral neck (+1.7% compared with placebo), with no significant effect at the lumbar spine (Calcified Tissue International, DOI) â a relevant study on the principle of vitamin K + D synergy, but not specifically on the K2-MK7 form.
Geleijnse et al. identified, in the Rotterdam cohort (4,807 participants), a significant inverse association between dietary menaquinone (K2) intake and the risk of coronary mortality and severe aortic calcification, while phylloquinone (K1) intake was associated with neither outcome (Journal of Nutrition, DOI). Regarding vitamin D and male hormonal health, Pilz et al. showed in 31 overweight men supplemented for one year (3,332 IU/day) a significant increase in total testosterone (by approximately 25%) as well as bioactive and free testosterone compared with placebo (Hormone and Metabolic Research, DOI) â an encouraging result obtained in overweight men following a weight-loss program, to be interpreted cautiously for other profiles.
Vitamin D3, K2-MK7, and zinc-magnesium: the Force Addict Pro selection to cover your micronutritional needs throughout the year.
D3 + K2-MK7 + Zinc-Magnesium: the micronutritional foundation for any athlete looking to support their health, recovery, and immune defenses.
To deepen your understanding of essential micronutrients and their role in athletic performance and health:
The vitamin D3 + K2-MK7 combination follows a consistent physiological rationale for bone and cardiovascular health, supported by solid data on each vitamin separately, although trials directly combining both molecules remain relatively limited. D3 optimizes calcium absorption and use and may support muscle performance; K2-MK7 helps direct this calcium toward bones and limit arterial calcification. At reasonable physiological doses â around 1,000 to 2,000 IU of D3 and 90 to 180 ”g of K2-MK7 per day â this stack generally has a favorable safety profile, particularly relevant for athletes, people with limited sun exposure, and seniors.
Prior assessment of serum vitamin D status remains the most rigorous approach before any corrective-dose supplementation. Integrated into an active lifestyle, a balanced diet, and targeted supplementation, D3 + K2-MK7 represents a relevant micronutritional investment â a conviction that Force Addict Pro reflects in each of its health and performance supplement selections.
Retrouvez les réponses aux questions les plus courantes avant votre achat.
La synerg ie repose sur une logique physiologique cohĂ©rente. La vitamine D3 augmente l'absorption intestinale du calcium â sans K2 suffisante, ce calcium pourrait thĂ©oriquement se dĂ©poser dans les parois artĂ©rielles plutĂŽt que dans les os. La vitamine K2 contribue Ă activer les protĂ©ines (ostĂ©ocalcine, MGP) qui dirigent le calcium vers les os. Geleijnse et al. (Journal of Nutrition, doi.org/10.1093/jn/134.11.3100) ont montrĂ© qu'un apport Ă©levĂ© en mĂ©naquinone (K2) Ă©tait associĂ© Ă un risque rĂ©duit de calcification aortique sĂ©vĂšre dans la cohorte Rotterdam. Prendre D3 seule Ă dose Ă©levĂ©e et prolongĂ©e sans K2 n'est pas nĂ©cessairement problĂ©matique pour la majoritĂ© des personnes, mais la combinaison rĂ©pond Ă une logique de cohĂ©rence physiologique plus complĂšte.
Les besoins varient selon le statut initial et l'exposition solaire. Une carence en vitamine D reste fréquente chez de nombreux sportifs européens, en particulier en hiver. Les doses d'entretien usuelles se situent entre 1000 et 2000 UI/jour pour la population générale, des doses plus élevées étant parfois utilisées en cas de carence avérée et sous suivi médical. Le dosage sanguin de la 25(OH)D reste l'outil le plus fiable pour ajuster la supplémentation à la situation individuelle, plutÎt qu'une dose standard appliquée sans vérification.
Les rĂ©cepteurs VDR (Vitamin D Receptor) prĂ©sents dans le tissu musculaire suggĂšrent un rĂŽle physiologique plausible de la vitamine D dans la fonction musculaire. Plusieurs Ă©tudes observationnelles associent un statut en D3 adĂ©quat Ă une meilleure force musculaire, en particulier chez les sujets initialement carencĂ©s. Le bĂ©nĂ©fice semble plus marquĂ© lorsque la supplĂ©mentation corrige un dĂ©ficit rĂ©el que chez des sportifs dĂ©jĂ bien pourvus, oĂč l'effet additionnel reste moins certain selon les donnĂ©es disponibles Ă ce jour.
La MK-7 (ménaquinone-7) présente une demi-vie nettement plus longue que la MK-4, ce qui permettrait un maintien plus stable des niveaux circulants avec une prise quotidienne unique. C'est l'une des raisons pour lesquelles la MK-7 est souvent privilégiée dans les compléments destinés à un usage quotidien simple. Les données comparatives directes entre les deux formes sur des critÚres cliniques (densité osseuse, santé cardiovasculaire) restent toutefois encore relativement limitées, la MK-7 étant la forme la mieux représentée dans les essais cliniques récents sur la santé osseuse.
Pilz et al. (Hormone and Metabolic Research, doi.org/10.1055/s-0030-1269854) ont menĂ© un essai randomisĂ© sur 31 hommes en surpoids supplĂ©mentĂ©s un an (3332 UI/jour) et observĂ© une augmentation significative de la testostĂ©rone totale (environ +25%), bioactive et libre par rapport au placebo. Il s'agit d'hommes en surpoids suivant un programme de perte de poids avec un dĂ©ficit initial en vitamine D â un contexte diffĂ©rent de sportifs entraĂźnĂ©s dĂ©jĂ bien pourvus en vitamine D, chez qui l'effet sur la testostĂ©rone n'est pas Ă©tabli avec la mĂȘme certitude. L'effet semble surtout pertinent en cas de carence avĂ©rĂ©e Ă corriger.
Le mĂ©canisme passe par la protĂ©ine MGP (Matrix Gla Protein), activĂ©e par la vitamine K, qui contribue Ă limiter la calcification de certains tissus mous. Knapen et al. (Osteoporosis International, doi.org/10.1007/s00198-013-2325-6) ont montrĂ© un effet positif de la K2-MK7 sur la densitĂ© osseuse et certains indices de rĂ©sistance osseuse sur 3 ans chez des femmes mĂ©nopausĂ©es â un rĂ©sultat pertinent pour la santĂ© osseuse en gĂ©nĂ©ral, mais les donnĂ©es spĂ©cifiques sur la santĂ© tendineuse et articulaire chez le sportif restent Ă ce jour plus limitĂ©es et mĂ©ritent d'ĂȘtre considĂ©rĂ©es avec prudence en l'absence d'Ă©tudes dĂ©diĂ©es Ă cette population.